Head of Financial Planning & Analysis

Cambridge, Massachusetts, United States Full-time

Evelo Biosciences is seeking an outstanding Head of FP&A

This is an outstanding opportunity to join a fast-paced company leveraging the previously untapped biology of the gut-body network to develop a new class of therapies that could transform the treatment of many major diseases, potentially providing profound benefits to patients and society. Evelo Biosciences is pioneering the development of therapies designed to act on the gut-body network – monoclonal microbials. Monoclonal microbials use naturally evolved pharmacology to work in the gut for effects throughout the body and comprise an entirely new class of potentially effective, convenient and safe medicines to address the unmet needs of huge numbers of patients with serious diseases. As a senior member of the Evelo team, you will play a vital role in creating this new modality of medicine.

We are seeking a Head of FP&A to join a highly dynamic and intellectually challenging team. This key leadership role will afford a qualified candidate an opportunity to work in an innovative, fast paced environment and shape Evelo’s vision to bring new products to patients. 

Reporting into the Chief Financial Officer, the Head of FP&A is a key leader at Evelo, supporting members of the Leadership team and their teams, providing insight and influence to help drive the growth and success of Evelo. The Head of FP&A is accountable for reinforcing and evolving a culture of collaborative data-driven decision making, constructive challenge, risk management and control to enable Evelo’s growth and success over the long term.

Primary Responsibilities:

  • Partner with the Leadership team and key leaders in company to help enable collaborative data-driven decision making, providing insight and influence to help drive the growth and success of Evelo.
  • Lead and evolve nimble FP&A processes to support business operations through insightful scenario-driven forward-looking decision making (budget, forecast, long range plan, ad hoc decision support)
  • Build FP&A function to support Evelo’s growth and business needs
  • Support financial analysis for corporate activities such as M&A, business development and financing
  • Lead finance support for functional leaders and project teams providing financial direction and strategic insight including identification of key value drivers and Business KPIs, helping functions and project teams deliver their short term and long-term goals and influencing strategy.
  • Develop and execute timely and value-added management reporting process
  • Coordinate with Corporate Controller input into monthly and quarterly close cycle, audits and quarterly reviews and SEC reporting activities
  • Support financial presentations to board of directors
  • In collaboration with the Corporate Controller
    • Reinforce and evolve a culture of controls at Evelo
    • Plan and evolve our finance systems environment, supporting well-designed processes with appropriate systems solutions to reinforce controls and increase efficiency
    • Ensure that delivery of finance and related services is seamless to the end user

Special Projects

  • Lead or support special projects, as necessary
    • Financial and operational due diligence on potential M&A targets and other business collaborations
    • Value added strategic analysis and modelling to support major investment decisions

Required Skills & Qualifications:

  • Strong communication, influencing and interpersonal skills necessary for daily interaction with Evelo leadership and peers across functions at Evelo.
  • Proven leadership and people management skills
  • Outstanding organizational skills and ability to manage complexity and lead multiple projects simultaneously.
  • Calm under pressure, ability to work independently and to manage and prioritize conflicting demands on time
  • Ability to serve as the face of Evelo for key external relationships.
  • Good judgment with a proven ability to make sound financial decisions
  • Strong analytical and financial skills to evaluate a broad range of financial questions – especially valuation, ROI/ROIC and complex business decisions.
  • Adept at problem-solving and creative thinking– substantial capacity to provide pragmatic solutions and possess the drive and leadership to implement ideas through to successful completion.
  • Demonstrated customer service focus – understanding of customer needs and desire to exceed expectations.

Education & Experience:

  • BS/BA degree in Finance, Accounting or an equivalent qualification. MBA in Finance or Management or CPA is preferred.
  • Minimum 10 -15 years of related industry experience in Corporate Finance, Business Analytics and/or Investment Banking
  • An excellent understanding of the biotechnology industry and the various functional areas; previous experience in financial planning and analysis and operations in a life sciences/biotech company
  • Demonstrated track record of success working in a team-based environment
  • Proven experience in building high performing teams in a rapidly growing company
  • Working knowledge and experience with biotech industry and biotech product life cycles.


About Evelo

Evelo Biosciences, Inc. is a clinical-stage biotechnology company developing a new modality of medicine, monoclonal microbials, which are designed to act on the gut-body network. Evelo’s product candidates are orally-delivered, single strains of microbes, selected for their defined pharmacological properties. They are intended to modulate systemic immunology and biology by acting on multiple naturally evolved biological pathways through the gut-body network. Evelo believes that monoclonal microbials have the potential to be broadly applicable across many diseases including immunoinflammatory, cancer, autoimmune, metabolic, neurological and neuroinflammatory diseases.

Evelo currently has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer, for which ten clinical readouts are expected during 2019 and 2020. Evelo is also advancing additional candidates through preclinical development in other disease areas.

For more information, please visit www.evelobio.com.

Apply for this opening at http://evelobio.recruiterbox.com/jobs/fk019n8?apply=true